Jonathan Zhang, PhD
Sanford School of Public Policy, Duke University, Durham, North Carolina; US Department of Veterans Affairs Office of Mental Health, Washington D.C.; National Bureau of Economic Research, Cambridge, Massachusetts
Original Research
GLP-1 Receptor Agonists and Overdose Risk in Veterans with Type 2 Diabetes and Opioid Use Disorder
July 15, 2026
Semaglutide and tirzepatide were associated with lower risk of all-cause overdose compared to insulin and SGLT2i inhibitors, but not metformin, sulfonylureas, or DPP4 inhibitors.
